Javascript must be enabled to continue!
Abstract 2398: S100P/RAGE signaling activates AP1 and NF-kB in miR-21/RECK regulation
View through CrossRef
Abstract
The receptor for advanced glycation end-products (RAGE) plays a role in different pathological diseases including cancer. Several ligands activate RAGE, among them are AGEs (advance glycation end-products), HMGB1 (amphoterin), amyloid-α peptide, and the S100 Ca2+ binding family. Activation of RAGE by S100P stimulates many cell processes in cancer mediated by AP1, NF-kB and ERK1/2. Recently, these transcription factors were shown to induce expression of the oncogene, miR-21. Our data show that S100P over-expression in LS174T and SW480 colon cancer cells induces miR-21 expression. It is well known that S100P has an intracellular and an extracellular function when it interacts with Ezrin and RAGE respectively. To decipher if the extracellular function of S100P mediated by its interaction with RAGE induces miR-21, we treated SW480 normally expressing RAGE and not S100P with exogenous human recombinant (hr)-S100P. These results show that S100P/RAGE signaling induces miR-21 expression. To determine if the induction of miR-21 by S100P/RAGE signaling is mediated by AP1 and NF-kB, we performed luciferase studies with wild type, and mutated AP1 and NF-kB pri-miR-21 promoter constructs in cells expressing only the RAGE receptor. These data show that S100P/RAGE signaling mediates miR-21 induction by the activation of AP1 and NF-kB. Additionally, LS174T cells expressing RAGE and S100P rendered similar results when they ectopically over-express S100P. However, ectopic S100P expression in SW480 cells induced miR-21 independent of AP1 and NF-kB. These results suggest that S100P has another mechanism of regulating miR-21. Our previous data indicated that over-expression of S100P down regulates the reversion-inducing cysteine-rich protein with Kazal motifs (RECK). RECK is an anti metastatic gene, inhibitor of metalloproteinases and a target of miR-21. Our data shows that RAGE expressing cells treated with exogenous hr-S100P down regulate RECK expression, suggesting that miR-21 induction by S100P/RAGE signaling represses RECK. To determine if there is a correlation in expression levels of miR-21 with RECK, RAGE, and S100P, we used the combined method of in situ hybridization (ISH) and immunohistochemical (IHC) techniques on human colorectal cancer tissues. We found that there are three groups of cells in the malignant epithelium as well as in the surrounding tissue. One group of cells expresses high levels of miR-21, another group expresses high levels of RECK while the third group expresses both. Together, these data show that S100P/RAGE regulates miR-21/RECK expression mediated by AP1 and NF-kB and suggest that in cancer this signaling pathway remodels the extracellular matrix by the activation of metalloproteinases inducing epithelial mesenchymal transition to allow cell migration/invasion in colon cancer progression.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2398. doi:1538-7445.AM2012-2398
American Association for Cancer Research (AACR)
Title: Abstract 2398: S100P/RAGE signaling activates AP1 and NF-kB in miR-21/RECK regulation
Description:
Abstract
The receptor for advanced glycation end-products (RAGE) plays a role in different pathological diseases including cancer.
Several ligands activate RAGE, among them are AGEs (advance glycation end-products), HMGB1 (amphoterin), amyloid-α peptide, and the S100 Ca2+ binding family.
Activation of RAGE by S100P stimulates many cell processes in cancer mediated by AP1, NF-kB and ERK1/2.
Recently, these transcription factors were shown to induce expression of the oncogene, miR-21.
Our data show that S100P over-expression in LS174T and SW480 colon cancer cells induces miR-21 expression.
It is well known that S100P has an intracellular and an extracellular function when it interacts with Ezrin and RAGE respectively.
To decipher if the extracellular function of S100P mediated by its interaction with RAGE induces miR-21, we treated SW480 normally expressing RAGE and not S100P with exogenous human recombinant (hr)-S100P.
These results show that S100P/RAGE signaling induces miR-21 expression.
To determine if the induction of miR-21 by S100P/RAGE signaling is mediated by AP1 and NF-kB, we performed luciferase studies with wild type, and mutated AP1 and NF-kB pri-miR-21 promoter constructs in cells expressing only the RAGE receptor.
These data show that S100P/RAGE signaling mediates miR-21 induction by the activation of AP1 and NF-kB.
Additionally, LS174T cells expressing RAGE and S100P rendered similar results when they ectopically over-express S100P.
However, ectopic S100P expression in SW480 cells induced miR-21 independent of AP1 and NF-kB.
These results suggest that S100P has another mechanism of regulating miR-21.
Our previous data indicated that over-expression of S100P down regulates the reversion-inducing cysteine-rich protein with Kazal motifs (RECK).
RECK is an anti metastatic gene, inhibitor of metalloproteinases and a target of miR-21.
Our data shows that RAGE expressing cells treated with exogenous hr-S100P down regulate RECK expression, suggesting that miR-21 induction by S100P/RAGE signaling represses RECK.
To determine if there is a correlation in expression levels of miR-21 with RECK, RAGE, and S100P, we used the combined method of in situ hybridization (ISH) and immunohistochemical (IHC) techniques on human colorectal cancer tissues.
We found that there are three groups of cells in the malignant epithelium as well as in the surrounding tissue.
One group of cells expresses high levels of miR-21, another group expresses high levels of RECK while the third group expresses both.
Together, these data show that S100P/RAGE regulates miR-21/RECK expression mediated by AP1 and NF-kB and suggest that in cancer this signaling pathway remodels the extracellular matrix by the activation of metalloproteinases inducing epithelial mesenchymal transition to allow cell migration/invasion in colon cancer progression.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL.
Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2398.
doi:1538-7445.
AM2012-2398.
Related Results
Abstract 1806: AP-1 transcriptionally regulates expression of miR-155 in colon cancer cells.
Abstract 1806: AP-1 transcriptionally regulates expression of miR-155 in colon cancer cells.
Abstract
Accumulating evidence indicates elevated S100P promotes the pathogenesis of cancers, including colon cancer. S100P exerts its effects by binding to and acti...
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Abstract
Background
MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apo...
Endothelial RAGE exacerbates acute postischaemic cardiac inflammation
Endothelial RAGE exacerbates acute postischaemic cardiac inflammation
SummaryAdvanced glycation end-products (AGEs) interact with their receptor RAGE, leading to an inflammatory state. We investigated the role of RAGE in postischaemic leukocyte adhes...
The effect of miR-138 on the proliferation and apoptosis of breast cancer cells
through the NF-κB/VEGF signaling pathway
The effect of miR-138 on the proliferation and apoptosis of breast cancer cells
through the NF-κB/VEGF signaling pathway
The analyze the effect of miR-138 on the proliferation and apoptosis of breast cancer cells through the
NF-κB/VEGF signaling pathway is the Objective of this experiment. For this a...
The effect of miRNAs and MALAT1 related with the prognosis of Her-2 positive breast cancer patients with lymph node metastasis
The effect of miRNAs and MALAT1 related with the prognosis of Her-2 positive breast cancer patients with lymph node metastasis
Abstract
Background: To analyze and screen the miRNAs associated with lymph node metastasis of breast cancer (BC), and to explore the roles of these miRNAs in the prolifera...
MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools
MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools
MicroRNAs (miRNAs) have been implicated in childhood acute lymphoblastic leukemia (ALL) pathogenesis. We performed a systematic review and meta-analysis of miRNA single-nucleotide ...
Abstract 1845: Cooperative function between miR-142-3p and miR-142-5p in hepatocellular carcinoma.
Abstract 1845: Cooperative function between miR-142-3p and miR-142-5p in hepatocellular carcinoma.
Abstract
MicroRNAs (miRNAs) are small non-coding RNAs regulate gene expression at post-transcriptional level and involved in a wide range of biological processes. Ab...
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
Abstract
Traditional research modes aim to find cancer-specific single therapeutic target. Recently, emerging evidence suggested that some micro-RNAs (miRNA) can fun...


